KRON
Price
$0.86
Change
-$0.02 (-2.27%)
Updated
Apr 24 closing price
Capitalization
52.49M
12 days until earnings call
VERA
Price
$23.47
Change
+$1.13 (+5.06%)
Updated
Apr 24 closing price
Capitalization
1.5B
13 days until earnings call
Ad is loading...

KRON vs VERA

Header iconKRON vs VERA Comparison
Open Charts KRON vs VERABanner chart's image
Kronos Bio
Price$0.86
Change-$0.02 (-2.27%)
Volume$68.74K
Capitalization52.49M
Vera Therapeutics
Price$23.47
Change+$1.13 (+5.06%)
Volume$588.49K
Capitalization1.5B
KRON vs VERA Comparison Chart
Loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRON vs. VERA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRON is a Buy and VERA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (KRON: $0.86 vs. VERA: $23.47)
Brand notoriety: KRON and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRON: 48% vs. VERA: 63%
Market capitalization -- KRON: $52.49M vs. VERA: $1.5B
KRON [@Biotechnology] is valued at $52.49M. VERA’s [@Biotechnology] market capitalization is $1.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRON’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • KRON’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, KRON is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRON’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 6 bullish TA indicator(s).

  • KRON’s TA Score: 5 bullish, 3 bearish.
  • VERA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VERA is a better buy in the short-term than KRON.

Price Growth

KRON (@Biotechnology) experienced а -3.04% price change this week, while VERA (@Biotechnology) price change was +10.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

KRON is expected to report earnings on Aug 07, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.5B) has a higher market cap than KRON($52.5M). KRON YTD gains are higher at: -9.368 vs. VERA (-44.502). KRON has higher annual earnings (EBITDA): -80.84M vs. VERA (-144.42M). VERA has more cash in the bank: 641M vs. KRON (125M). KRON has less debt than VERA: KRON (25.8M) vs VERA (54.6M). KRON has higher revenues than VERA: KRON (9.86M) vs VERA (0).
KRONVERAKRON / VERA
Capitalization52.5M1.5B4%
EBITDA-80.84M-144.42M56%
Gain YTD-9.368-44.50221%
P/E RatioN/AN/A-
Revenue9.86M0-
Total Cash125M641M20%
Total Debt25.8M54.6M47%
TECHNICAL ANALYSIS
Technical Analysis
KRONVERA
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 17 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSP158.209.83
+6.63%
Inspire Medical Systems
CAN0.800.01
+0.95%
Canaan
PRT3.930.01
+0.26%
PermRock Royalty Trust Trust
GILD106.15-0.23
-0.22%
Gilead Sciences
CSGS58.69-0.40
-0.68%
CSG Systems International

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with CYTK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
-2.17%
CYTK - KRON
42%
Loosely correlated
+6.13%
VERA - KRON
38%
Loosely correlated
+5.06%
AXON - KRON
38%
Loosely correlated
+2.39%
ARRY - KRON
37%
Loosely correlated
+5.31%
BTAI - KRON
36%
Loosely correlated
+9.47%
More